Show simple item record

dc.contributor.authorYonem, Ozlem
dc.contributor.authorArslan, Serab
dc.contributor.authorSokmensuer, Cenk
dc.contributor.authorSalmanzade, Selale
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T10:13:43Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T10:13:43Z
dc.date.issued2010
dc.identifier.issn0172-6390
dc.identifier.urihttps://hdl.handle.net/20.500.12418/9891
dc.descriptionWOS: 000280557900033en_US
dc.descriptionPubMed ID: 20698227en_US
dc.description.abstractBackground/Aims: Recently ribavirin has been found to inhibit angiogenesis and a number of angiogenesis inhibitors such as sunitinib and sorafenib have been found to cause acute hemolysis. We aimed to investigate whether there is a relation between hemoglobin, haptoglobin and angiogenesis soluble markers which are modifiable and can help in developing strategies against anemia. Methods: Fourteen patients chronically infected with hepatitis C virus were treated by pegylated interferon alpha 2a and ribavirin. Serum hemoglobin, haptoglobin and angiogenesis markers of vascular endothelial growth factor and angiopoetin-2 were investigated before and after therapy. Results: We observed a significant decrease in haptoglobin levels at the end of the treatment period. Hemoglobin levels also decreased but insignificantly by treatment. In contrast with the literature, serum levels of angiogenesis factors did not change significantly by pegylated interferon and ribavirin therapy. We found no correlation of angiogenesis soluble markers with either hemoglobin or haptoglobin. Conclusion: This is the first study in the literature investigating a link between angiogenesis soluble markers and ribavirin induced anemia in patients with hepatitis C and we could not find any relation. Future research with larger number of patients is needed to find out modifiable factors that will improve the safety of ribavirin therapy.en_US
dc.language.isoengen_US
dc.publisherH G E UPDATE MEDICAL PUBLISHING S Aen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis Cen_US
dc.subjectRibavirinen_US
dc.subjectHemolytic anemiaen_US
dc.subjectAngiogenesisen_US
dc.titleCan Angiogenesis be a Target of Treatment for Ribavirin Associated Hemolytic Anemia?en_US
dc.typearticleen_US
dc.relation.journalHEPATO-GASTROENTEROLOGYen_US
dc.contributor.department[Yonem, Ozlem] Cumhuriyet Univ, Dept Gastroenterol, TR-58140 Sivas, Turkey -- Cumhuriyet Univ, Dept Pathol, TR-58140 Sivas, Turkey -- Hacettepe Univ, Dept Gastroenterol, Ankara, Turkey -- Hacettepe Univ, Dept Pathol, Ankara, Turkeyen_US
dc.identifier.volume57en_US
dc.identifier.issue99-100en_US
dc.identifier.endpage566en_US
dc.identifier.startpage562en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record